Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Apexbio Technology LLC PKI 14-22 amide, myristoylated 201422-03-9 1mg
Supplier: Apexbio Technology LLC B90091
PKI 14-22 amide myristoylated (CAS 201422-03-9) is a cell-permeable inhibitor of cAMP-dependent protein kinase (PKA) By competitively blocking PKA activity this peptide fragment interferes with the phosphorylation of serine/threonine residues on protein substrates thereby modulating downstream signaling pathways involved in gene expression apoptosis differentiation and cell proliferation In cellular models myristoylated PKI 14-22 amide inhibits PKA-mediated processes such as 8-bromo-cAMP-induced hyperalgesia and IgG-Fc receptor stimulated phagocytosis in neutrophils in a dose-dependent manner This compound serves as a valuable research tool for dissecting PKA function and exploring PKA-related pathophysiology including cancer and immune regulation
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?